Subcutaneous Uptake on [18F]Florbetaben PET/CT: a Case Report of Possible Amyloid-Beta Immune-Reactivity After COVID-19 Vaccination

INTRODUCTION: Large-scale worldwide COVID-19 vaccination programs are being rapidly deployed, and high-risk patients with comorbidity are now receiving the first doses of the vaccine. Physicians should be, therefore, aware of new pitfalls associated with the current pandemic vaccination program, als...

Descripción completa

Detalles Bibliográficos
Autores principales: Laudicella, Riccardo, Burger, Irene Andrea, Panasiti, Francesco, Longo, Costanza, Scalisi, Salvatore, Minutoli, Fabio, Baldari, Sergio, Grimaldi, Luigi Maria Edoardo, Alongi, Pierpaolo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8439537/
https://www.ncbi.nlm.nih.gov/pubmed/34541458
http://dx.doi.org/10.1007/s42399-021-01058-0
_version_ 1783752540084502528
author Laudicella, Riccardo
Burger, Irene Andrea
Panasiti, Francesco
Longo, Costanza
Scalisi, Salvatore
Minutoli, Fabio
Baldari, Sergio
Grimaldi, Luigi Maria Edoardo
Alongi, Pierpaolo
author_facet Laudicella, Riccardo
Burger, Irene Andrea
Panasiti, Francesco
Longo, Costanza
Scalisi, Salvatore
Minutoli, Fabio
Baldari, Sergio
Grimaldi, Luigi Maria Edoardo
Alongi, Pierpaolo
author_sort Laudicella, Riccardo
collection PubMed
description INTRODUCTION: Large-scale worldwide COVID-19 vaccination programs are being rapidly deployed, and high-risk patients with comorbidity are now receiving the first doses of the vaccine. Physicians should be, therefore, aware of new pitfalls associated with the current pandemic vaccination program, also in the case of [(18)F]Florbetaben PET/CT. Case Presentation We described the first image of [(18)F]Florbetaben PET/CT in the evaluation of a 70-year-old male with suspicious Alzheimer disease and unclear history of heart disease. We detailed the diagnostic imaging PET/CT workup with different findings. CONCLUSION: In this case, [(18)F]Florbetaben PET/CT can demonstrate potential beta-amyloid immune-reactivity and deposition associated with the current COVID-19 pandemic vaccination programs.
format Online
Article
Text
id pubmed-8439537
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-84395372021-09-15 Subcutaneous Uptake on [18F]Florbetaben PET/CT: a Case Report of Possible Amyloid-Beta Immune-Reactivity After COVID-19 Vaccination Laudicella, Riccardo Burger, Irene Andrea Panasiti, Francesco Longo, Costanza Scalisi, Salvatore Minutoli, Fabio Baldari, Sergio Grimaldi, Luigi Maria Edoardo Alongi, Pierpaolo SN Compr Clin Med Case Report INTRODUCTION: Large-scale worldwide COVID-19 vaccination programs are being rapidly deployed, and high-risk patients with comorbidity are now receiving the first doses of the vaccine. Physicians should be, therefore, aware of new pitfalls associated with the current pandemic vaccination program, also in the case of [(18)F]Florbetaben PET/CT. Case Presentation We described the first image of [(18)F]Florbetaben PET/CT in the evaluation of a 70-year-old male with suspicious Alzheimer disease and unclear history of heart disease. We detailed the diagnostic imaging PET/CT workup with different findings. CONCLUSION: In this case, [(18)F]Florbetaben PET/CT can demonstrate potential beta-amyloid immune-reactivity and deposition associated with the current COVID-19 pandemic vaccination programs. Springer International Publishing 2021-09-14 2021 /pmc/articles/PMC8439537/ /pubmed/34541458 http://dx.doi.org/10.1007/s42399-021-01058-0 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Case Report
Laudicella, Riccardo
Burger, Irene Andrea
Panasiti, Francesco
Longo, Costanza
Scalisi, Salvatore
Minutoli, Fabio
Baldari, Sergio
Grimaldi, Luigi Maria Edoardo
Alongi, Pierpaolo
Subcutaneous Uptake on [18F]Florbetaben PET/CT: a Case Report of Possible Amyloid-Beta Immune-Reactivity After COVID-19 Vaccination
title Subcutaneous Uptake on [18F]Florbetaben PET/CT: a Case Report of Possible Amyloid-Beta Immune-Reactivity After COVID-19 Vaccination
title_full Subcutaneous Uptake on [18F]Florbetaben PET/CT: a Case Report of Possible Amyloid-Beta Immune-Reactivity After COVID-19 Vaccination
title_fullStr Subcutaneous Uptake on [18F]Florbetaben PET/CT: a Case Report of Possible Amyloid-Beta Immune-Reactivity After COVID-19 Vaccination
title_full_unstemmed Subcutaneous Uptake on [18F]Florbetaben PET/CT: a Case Report of Possible Amyloid-Beta Immune-Reactivity After COVID-19 Vaccination
title_short Subcutaneous Uptake on [18F]Florbetaben PET/CT: a Case Report of Possible Amyloid-Beta Immune-Reactivity After COVID-19 Vaccination
title_sort subcutaneous uptake on [18f]florbetaben pet/ct: a case report of possible amyloid-beta immune-reactivity after covid-19 vaccination
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8439537/
https://www.ncbi.nlm.nih.gov/pubmed/34541458
http://dx.doi.org/10.1007/s42399-021-01058-0
work_keys_str_mv AT laudicellariccardo subcutaneousuptakeon18fflorbetabenpetctacasereportofpossibleamyloidbetaimmunereactivityaftercovid19vaccination
AT burgerireneandrea subcutaneousuptakeon18fflorbetabenpetctacasereportofpossibleamyloidbetaimmunereactivityaftercovid19vaccination
AT panasitifrancesco subcutaneousuptakeon18fflorbetabenpetctacasereportofpossibleamyloidbetaimmunereactivityaftercovid19vaccination
AT longocostanza subcutaneousuptakeon18fflorbetabenpetctacasereportofpossibleamyloidbetaimmunereactivityaftercovid19vaccination
AT scalisisalvatore subcutaneousuptakeon18fflorbetabenpetctacasereportofpossibleamyloidbetaimmunereactivityaftercovid19vaccination
AT minutolifabio subcutaneousuptakeon18fflorbetabenpetctacasereportofpossibleamyloidbetaimmunereactivityaftercovid19vaccination
AT baldarisergio subcutaneousuptakeon18fflorbetabenpetctacasereportofpossibleamyloidbetaimmunereactivityaftercovid19vaccination
AT grimaldiluigimariaedoardo subcutaneousuptakeon18fflorbetabenpetctacasereportofpossibleamyloidbetaimmunereactivityaftercovid19vaccination
AT alongipierpaolo subcutaneousuptakeon18fflorbetabenpetctacasereportofpossibleamyloidbetaimmunereactivityaftercovid19vaccination

Ejemplares similares